Company news
Bio-Thera Solutions, Ltd. news in 2024
Bio-Thera Solutions, Ltd.'s news releases, calls and decks from 2024, newest first.
Bio-Thera Solutions Expands Partnership With SteinCares To Market Two Biosimilars In LATAM
December 30, 2024
Bio-Thera And Gedeon Richter Reach Exclusive Commercialization Agreement For Ustekinumab Biosimilar
November 4, 2024
Bio-Thera Solutions Initiates Integrated Phase I / Phase III Clinical Trial for BAT3306, a Proposed Biosimilar of Keytruda
July 26, 2024
Bio-Thera and STADA Reach Exclusive Agreement for BAT2506, a Proposed Golimumab Biosimilar, in the EU and UK
May 29, 2024
Bio-Thera Solutions Receives IND Clearance from US FDA to Initiate a Phase II Study for BAT8006, an Innovative Antibody Drug Conjugate Targeting Folate Receptor
March 26, 2024